Elizabeth C. de Boer

Author

Also Known As

E C de Boer, E. C. Boer, E. C. De Boer, E. C. de Boer, E.C. DE BOER, E.C. de Boer, ELIZABETH C. DE BOER, ELIZABETH C. de BOER, Elizabeth C. De Boer, Elizabeth C. de Boer

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam National Institute for Public Health and the Environment Radboud University Nijmegen Havenziekenhuis Rotterdam Rijnland Ziekenhuis

About

Elizabeth C. de Boer is an author at University of Amsterdam specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	793
2	Immunology	6	6	430
3	Cell Biology	2	2	91
4	Allergy	1	1	26
5	Anesthesia	1	1	21

Elizabeth C. de Boer

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg, Cancer Immunology Immunotherapy Tumour Necrosis FactorUrologyCancer ImmunosurveillanceGenitourinary CancerSuperficial Bladder Cancer	1992	198
Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic Value Theo M. de Reijke, Elizabeth C. de Boer, Karl H. Kurth, The Journal of Urology	1996	181
Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden, Cancer Immunology Immunotherapy Urological ResearchUrologyGenitourinary CancerSuperficial Bladder CancerMedicine	1991	111
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer Elizabeth C. de Boer, Wim H. de Jong, A.P.M. van der Meijden, Urological Research Urological ResearchUrologyGenitourinary CancerSuperficial Bladder CancerMedicine	1991	100
Role of interleukin-8 in onset of the immune response in intravesical BCG therapy for superficial bladder cancer Elizabeth C. de Boer, László Somogyi, G. J. W. De Ruiter, Urological Research UrologyCancer ImmunosurveillanceGenitourinary CancerSuperficial Bladder CancerIntravesical Bcg Therapy	1997	74
Immunotherapy of Experimental Bladder Cancer with Recombinant BCG Expressing Interferon-γ Judith Arnold, Elizabeth C. de Boer, Michael A. O’Donnell, Journal of Immunotherapy	2004	61
Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Guerin (BCG) T.M. De Reijke, Pieter C. Vos, Elizabeth C. de Boer, Urological Research CytokineUrologyBacillus Calmette-guerinGenitourinary CancerImmunology	1993	58
BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines. Rob F. M. Bevers, Elizabeth C. de Boer, K. H. Kurth, PubMed ImmunologyImmunoeditingImmunologic MechanismImmunotherapyCancer Biology	1998	54
URINARY INTERLEUKIN-2 MONITORING DURING PROLONGED BACILLUS CALMETTE-GUERIN TREATMENT: CAN IT PREDICT THE OPTIMAL NUMBER OF INSTILLATIONS? Theo M. de Reijke, Elizabeth C. de Boer, Karl H. Kurth, The Journal of Urology	1999	48
The Bard<sup>&reg;</sup> BTA Test: Its Mode of Action, Sensitivity and Specificity, Compared to Cytology of Voided Urine, in the Diagnosis of Superficial Bladder Cancer Denis Schamhart, Theo M. de Reijke, H.G. Van Der Poel, European Urology Voided UrineUrological ResearchUrologyVoiding DysfunctionGenitourinary Cancer	1998	43

Page 1